Mirae Asset Global Etfs Holdings Ltd. Travere Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 44,284 shares of TVTX stock, worth $635,475. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,284Holding current value
$635,475% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TVTX
# of Institutions
184Shares Held
89.8MCall Options Held
137KPut Options Held
181K-
Black Rock Inc. New York, NY7.64MShares$110 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.5MShares$108 Million0.8% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.37MShares$106 Million1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.62MShares$95 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.48MShares$64.3 Million1.14% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $921M
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...